Home News & Events Events Workshops Workshops Workshop Beginners/Intermediate Online NONMEM/PDx-Pop workshop Date 27 January 2026 - 28 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Workshop Advanced Online NONMEM/PDx-Pop workshop Date 29 January 2026 Time 09:00 - 16:00 Location Online/Virtual Webex Timezone America/New York Workshop New and Advanced Features of NONMEM 7.6 Workshop Date 1 June 2026 Time 09:00 - 17:00 Location Dubrovnik, Croatia Timezone Europe/Bratislava In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events Webinars Workshops Webinars Social media Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related Information Webpage Webinars Webpage Industry Events What’s happening in ICON ICON Plc Careers in finance look different when you are close to the centre of a global organisation. At ICON’s Dublin headquarters, our finance professionals gain exposure across regions, work closely with senior leaders, and a... 11h View post View webpage ICON Plc Is AI enough? Artificial intelligence has revolutionised site identification, but it’s not the whole story. At SCOPE 2026, join Travis Caudill, VP – Feasibility, Site Selection & Medical Informatics, as he explores why s... 14h View post View webpage ICON Plc Long-term follow-up for vaccines may seem to be a distant concern when clinical trials are just beginning, but it can be critical to have a plan for follow-up at the outset. Learn considerations for follow-up design, s... 16h View post View webpage ICON Plc In 2025 ICON was recognised for its commitment to building an inclusive workplace. Learn more. https://ow.ly/uWXN50XSPUE 18h View post View webpage ICON Plc At ICON, we understand that exploring a new career opportunity comes with questions. Having a clear sense of what to expect can make the experience feel more straightforward. This week, we’re sharing a five part series ... 19h View post View webpage ICON Plc The development of longer-acting and more potent NUSH receptor agonists, like semaglutide, has helped clarify the link between aberrant glucose metabolism and a range of diseases. Learn how to embrace the multi-indicatio... 23 Jan View post View webpage ICON Plc PubsHub Journals & Congresses now includes publication AI policy guidelines, ensuring ethical use and transparency in research. Whether you use AI to analyze data or draft manuscripts, learn what’s required for complianc... 22 Jan View post View webpage ICON Plc ICON is heading to SCOPE 2026 From labs and patient solutions to site strategies and biosimilars, our experts will be on the ground in Orlando from 2–5 February. We’re ready to share insights on accelerating clinical de... 21 Jan View post View webpage ICON Plc To unlock the full value of emerging multi-indication therapies, developers must adopt strategies that prioritise early cross-functional planning and innovative trial architecture. ICON’s Jack Martin and Alan Baldridge... 21 Jan View post View webpage ICON Plc Product labelling and promotional materials are the foundation of pharma communication and effective pharmaceutical communications begin with a strategic vision anchored in the product label. Regulatory change often br... 21 Jan View post View webpage ICON Plc #OCTWestCoast will be returning to Burlingame for the 18th annual event on 11-12 February. Pass by booth \#79 and engage in an insightful discussion with ICON Biotech’s professionals regarding the latest challenges and s... 20 Jan View post View webpage ICON Plc In 2025 ICON was independently recognised as a leading CRO for both Ph1 and Ph 2/3 studies and was also awarded Best CRO in APAC. Learn more. https://ow.ly/wfMb50XSPQG 20 Jan View post View webpage
